Literature DB >> 2019758

Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture.

S M Levitz1, T P Farrell, R T Maziarz.   

Abstract

Since cell-mediated immunity (CMI) is critical for host defenses against the encapsulated fungus Cryptococcus neoformans, the production of human antifungal effector cells as a consequence of the CMI response was investigated. Peripheral blood mononuclear cells (PBMC) were stimulated in culture with killed C. neoformans. Stimulated (but not unstimulated) PBMC killed a subsequent inoculum of live encapsulated organisms, with maximal killing seen after 3-7 days. Killing required the presence of both adherent and nonadherent stimulated PBMC and was enhanced by anticapsular antibody. In contrast, unstimulated PBMC and the adherent fraction of stimulated PBMC killed an isogenic acapsular strain of C. neoformans. These data suggest that the CMI response controls cryptococcosis by eliciting two populations of fungicidal cells acting synergistically. Moreover, capsule, by thwarting the ability of unstimulated PBMC to kill C. neoformans, seems to obligate the host to mount an immune response to generate fungicidal cells.

Entities:  

Mesh:

Year:  1991        PMID: 2019758     DOI: 10.1093/infdis/163.5.1108

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; G Spira; J Oh; M Paizi; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 2.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Intravascular granuloma induced by intravenous inoculation of Cryptococcus neoformans.

Authors:  H Yamaoka; N Sakaguchi; K Sano; M Ito
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 6.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

7.  Effect of endothelial cells on phagocyte-mediated anticryptococcal activity.

Authors:  S A Roseff; S M Levitz
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.

Authors:  J W Murphy; M R Hidore; S C Wong
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.